Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Hippocampal volume and 2-year outcome indepression

  • Klaus-Thomas Kronmüller, Johannes Pantel, Sebastian Köhler, Daniela Victor, Frederik Giesel, Vincent A. Magnotta, Christoph Mundt, Marco Essig, Johannes Schröder
  • Journal:
    The British Journal of Psychiatry / Volume 192 / Issue 6 / June 2008
    Published online by Cambridge University Press:
    02 January 2018, pp. 472-473
    Print publication:
    June 2008
    • Article
      • You have access
    • PDF
    • HTML
    • Export citation

  • Although the hippocampus has been found to be smaller in people withdepression, the clinical relevance of this is unclear. We investigatedhippocampal volume (using high-resolution magnetic resonance imaging) and2-year outcome in 57 patients with major depression. The left and righthippocampal volumes of patients with a depression relapse were significantlysmaller than those of healthy controls. Our results support the hypothesisthat the hippocampus is crucial in the outcome of depression.

  • Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia

  • NIELS BERGEMANN, PETER PARZER, BENNO RUNNEBAUM, FRANZ RESCH, CHRISTOPH MUNDT
  • Journal:
    Psychological Medicine / Volume 37 / Issue 10 / October 2007
    Published online by Cambridge University Press:
    24 April 2007, pp. 1427-1436
  • Background

    Estrogen has been hypothesized to have a protective and antipsychotic-like effect in women at risk for schizophrenia. The aim of the present study was to evaluate the association between menstrual cycle and/or estrogen levels and psychotic symptoms in a sample of women with schizophrenia.

    Method

    One hundred and twenty-five premenopausal women with schizophrenia and regular menses were examined. The levels of 17β-estradiol and other hormones of the gonadal axis were assessed in the follicular, peri-ovulatory, and luteal phases of the menstrual cycle. The effects of the menstrual cycle phase and/or the estradiol level on the Positive and Negative Syndrome Scale (PANSS) and the Brief Psychiatric Rating Scale (BPRS) scores were calculated by means of regression analyses.

    Results

    Significant improvement in psychotic, but not depressive, symptoms was observed during the luteal phase, compared with other days of the menstrual cycle.

    Conclusions

    The present findings indicate that estradiol may have specific antipsychotic-like effects on the symptoms of schizophrenia. Thus further investigation into the therapeutic effect of estrogen may be worthwhile.